ArticleFrontiers in endocrinology2022

A Case Report: First Long-Term Treatment With Burosumab in a Patient With Cutaneous-Skeletal Hypophosphatemia Syndrome.

Lea Maria Merz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.